Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing to Advance its mRNA-Based Vaccine and Therapeutic Development

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2QmUrzV
via IFTTT